Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 PRISM-PLUS: 30-day death/MI by strategy. Benefit of upstream tirofiban stratified by the ultimate treatment strategy employed. CI = confidence interval; CABG = coronary artery bypass graft; MI = myocardial infarction; PRISM-PLUS = the Platelet Receptor inhibition for ISchemic Management in Patients Limited to very Unstable Signs and Symptoms; PTCA = percutaneous transluminal coronary angioplasty; Rx = treatment. Data from Barr E, Thornton AR, Sax FL, Snapinn SM, Theroux P. Benefit of tirofiban + heparin therapy in unstable angina/non–Q-wave myocardial infarction patients is observed regardless of interventional treatment. Circulation 1998;98 Suppl I:I504. Reprinted with permission from Lippincott, Williams and Wilkins.
|
